{"id":8755,"date":"2022-03-03T11:16:10","date_gmt":"2022-03-03T09:16:10","guid":{"rendered":"https:\/\/canatu.com\/?p=8755"},"modified":"2025-10-03T07:51:35","modified_gmt":"2025-10-03T04:51:35","slug":"iprs-and-patents-in-nanotechnology","status":"publish","type":"post","link":"https:\/\/canatu.com\/company\/carbon-age-news\/iprs-and-patents-in-nanotechnology\/","title":{"rendered":"Pushing the boundaries of innovation with fully-owned IPR"},"content":{"rendered":"\n

Canatu has full control over the manufacturing and development of Canatu carbon nanotubes (Canatu CNT). Owning the intellectual property rights (IPR) gives us a fruitful platform and freedom to innovate. Since the inception, we have systematically developed our patent portfolio to create essential protection for the Canatu CNT material itself, its manufacturing, synthesis and post-processing processes as well as different applications. As of 2022, Canatu holds over 150 patents and pending in 25 different categories<\/strong>. <\/p>\n\n\n\n

\n

“We are steadily moving towards a world that will depend on carbon based solutions for progress. By maintaining an extensive IPR portfolio, we not only drive growth and innovation for the company, but also ensure that we hold a significant stake in the future.”<\/p>\nIlkka Varjos, CTO of Canatu<\/cite><\/blockquote>\n\n\n\n

Controlling the entire process gives us an advantage to advance Canatu CNT and develop applications with partners, and we continue to push boundaries every day, developing Canatu CNT for new applications and customers.<\/p>\n\n\n\n

Currently, Canatu is on track to double its annual patents<\/strong> filed compared to previous years, signaling an upward trend in novel breakthroughs that are likely to achieve commercial success. This has been made possible largely due to Canatu’s continuous drive to innovate, as exemplified by the company’s employee invention policy that incentives the creation of solutions that can be protected by a patent and\/or utility model.<\/p>\n\n\n\n

IPR is the backbone of Canatu<\/h3>\n\n\n\n

Broad IPR portfolio ensures that Canatu can protect its innovations and unique processes, whilst also providing advantageous business opportunities in the form of licensing arrangements with third parties. <\/p>\n\n\n\n

Canatu’s portfolio can be contrasted with other companies that only retain the IPRs over an individual aspect of the production process, e.g. their own nanomaterial or one step in the manufacturing process. In this case, a company with its own proprietary CNT powder would need to rely on third party companies to carry out other aspects of the manufacturing process to bring a product to market. Conversely, Canatu’s IPR portfolio protects everything from our manufacturing and product platforms to the final product. For example, Canatu has developed its own unique manufacturing processes in-house, including its patented dry deposition method which reduces the number of steps to make deposits whilst increasing the overall quality and performance of the final product.<\/p>\n\n\n\n

As Canatu enters new applications this requires the development of novel solutions which can often be patent protected. This strengthens Canatu’s IPR position in the domain. <\/p>\n\n\n\n

\"\"
Canatu’s comprehensive portfolio includes IPRs covering our CNT material technology, manufacturing and product platforms, as well as the final products.<\/figcaption><\/figure>\n\n\n\n

With its extensive IPR portfolio, Canatu is able to:<\/p>\n\n\n\n